2026 Laboratory Medicine Congress & Exhibition (LMCE)

The Laboratory Medicine Congress & Exhibition (LMCE) 2026 will take place from October 21–23, 2026, at Grand Walkerhill Seoul, South Korea.

Illumina will participate in LMCE 2026 to engage with clinical laboratory professionals and molecular diagnostics experts, showcasing how next-generation sequencing (NGS) and artificial intelligence are advancing precision medicine.

At this year's meeting, Illumina will highlight its WGS-based MRD solution for highly sensitive cancer monitoring and AI-powered genomic interpretation tools that help improve variant prioritization and clinical insights. Through booth engagement and an educational workshop, attendees will learn how Illumina's integrated sequencing, bioinformatics, and AI capabilities support oncology and rare disease applications.

Aligned with the growing adoption of precision oncology and AI-assisted diagnostics, Illumina aims to demonstrate practical clinical applications that enable more confident and actionable genomic decision-making.

Session Details

The Illumina educational workshop will focus on the latest advances in clinical genomics, featuring AI-powered genomic interpretation and WGS-based MRD monitoring technologies for oncology and molecular diagnostics.

Workshop Information

• Date & Time: October 22, 2026 | 08:00 AM
• Speakers: Steve Lee & Jeongmin Kim
• Talk Title: Innovation in Clinical Genomics in the AI Era: Oncology, MRD WGS, and ILMN Software

Abstract:

AI-driven technologies are transforming clinical genomics by enabling faster and more accurate genomic interpretation. During this session, Illumina will showcase AI-powered tools, including PrimateAI-3D, SpliceAI, and PromoterAI, as well as Explainable AI applications through Emedgene and Oncology Interpretation solutions. The presentation will also highlight Illumina's WGS-based tumor-informed MRD technology, demonstrating highly sensitive cancer monitoring and recurrence detection using ultra-low levels of ctDNA.